MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells

Shufeng Liu1, Chao Qiu, Ruidong Miao

  • 1Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA 15261.

Insights

Monocyte chemotactic protein-induced protein 1 (MCPIP1) restricts HIV-1 production in CD4+ T cells by degrading viral mRNA. Cellular activation triggers MCPIP1 degradation, enhancing HIV-1 production.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) predominantly infects activated CD4+ T cells and macrophages.
  • Quiescent CD4+ T cells possess intrinsic factors that inhibit HIV-1 replication post-entry.

Purpose of the Study:

  • To investigate the role of monocyte chemotactic protein-induced protein 1 (MCPIP1) in restricting HIV-1 production in CD4+ T cells.
  • To elucidate the mechanism by which MCPIP1 affects HIV-1 replication.

Main Methods:

  • Ectopic expression and silencing of MCPIP1 in cell lines and primary CD4+ T cells.
  • Analysis of viral mRNA levels and protein production.
  • Investigation of MCPIP1 degradation pathways using proteasome inhibitors (e.g., MG132).

Main Results:

  • MCPIP1 expression abolished HIV-1 production, while MCPIP1 silencing enhanced it.
  • MCPIP1 restricts HIV-1 by reducing viral mRNA levels via its RNase domain.
  • T-cell activation rapidly degrades MCPIP1, leading to increased HIV-1 production.

Conclusions:

  • MCPIP1 acts as a post-transcriptional barrier against HIV-1 replication in CD4+ T cells.
  • Cellular activation-induced degradation of MCPIP1 facilitates HIV-1 production.
  • Understanding MCPIP1 regulation offers insights into HIV-1 latency and reactivation.